TELA Bio (TELA) EBT Margin (2018 - 2026)
TELA Bio's (TELA) quarterly EBT Margin came in at 64.08% in Q1 2026, down 354.0% year-on-year from 25.23% in Q1 2025, and down 50.32% quarter-over-quarter from 42.63% in Q4 2025.
TELA Bio (TELA) EBT Margin (2018 - 2026) Analysis & Trends
TELA Bio's EBT Margin history runs 9 years deep, the most recent figure standing at 64.08% for Q1 2026.
- On a quarterly basis, EBT Margin fell 354.0% year-over-year to 64.08% in Q1 2026; TTM through Mar 2026 was 49.0%, a 4207.0% decrease from a year earlier, with the FY2025 full-year figure at 48.09%, down 4897.0% from the prior year.
- EBT Margin fell to 64.08% in Q1 2026 per TELA's latest filing, from 42.63% in the prior quarter.
- Across five years, EBT Margin topped out at 165.72% in Q4 2024 and bottomed at 135.77% in Q1 2022.
- The 5-year median for EBT Margin is 76.49% (2023), against an average of 60.27%.
- Across the five-year window, EBT Margin jumped 24221 bps in 2024 and sank 20835 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 83.2% in 2022, then advanced by 8 bps to 76.49% in 2023, then surged by 317 bps to 165.72% in 2024, then tumbled by 126 bps to 42.63% in 2025, then slumped by 50 bps to 64.08% in 2026.
- Per Business Quant, the three latest TELA EBT Margin figures stand at 64.08% (Q1 2026), 42.63% (Q4 2025), and 41.58% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | -64.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.08% |
| Dec 31, 2025 | -42.63% |
| Sep 30, 2025 | -41.58% |
| Jun 30, 2025 | -48.97% |
| Mar 31, 2025 | -60.54% |
| Dec 31, 2024 | 165.72% |
| Sep 30, 2024 | -54.71% |
| Jun 30, 2024 | -78.30% |
| Mar 31, 2024 | -34.10% |
| Dec 31, 2023 | -76.49% |
| Sep 30, 2023 | -76.50% |
| Jun 30, 2023 | -85.29% |
| Mar 31, 2023 | -104.96% |
| Dec 31, 2022 | -83.20% |
| Sep 30, 2022 | -95.77% |
| Jun 30, 2022 | -107.35% |
| Mar 31, 2022 | -135.77% |
| Dec 31, 2021 | -102.15% |
| Sep 30, 2021 | -147.86% |
| Jun 30, 2021 | -194.64% |